Omar [indiscernible]'s questions to Auna SA (AUNA) leadership • Q1 2025
Question
Omar [indiscernible] asked for Auna's 2025 EBITDA and CapEx guidance, whether to expect more impairments in Colombia, and the current status of the Oncosalud deployment in Mexico.
Answer
CFO and Executive Vice President Gisele Ferrero reiterated that no specific EBITDA guidance was given and that CapEx is expected to be at or below $50 million. She confirmed that impairments in Colombia will continue as a balance sheet de-risking measure, but the company expects to collect on those accounts. Executive Chairman and President Jesús Zamora Leon added that the Oncosalud Mexico rollout is progressing well, with a national network now secured in four major cities.